Participating Faculty: Evolving Strategies for the Management of Multiple Myeloma: A Managed Care Perspective

February 24, 2014
Ira M. Klein, MD, MBA, FACP

,
Ralph V. Boccia, MD, FACP

,
Eric Cannon, PharmD, FAMCP

,
William J. Cardarelli, PharmD

,
Bo Gamble, BSBA

,
Linda House, RN, BSN, MSM

,
David H. Howard, PhD

,
Mary Malloy, BA, CA

Supplements and Featured Publications, Evolving Strategies for the Management of Multiple Myeloma: A Managed Care Perspective, Volume 20, Issue 2 Suppl

This supplement to The American Journal of Managed Care summarizes proceedings from a roundtable meeting that was conducted to discuss the perspectives of the faculty on several topics related to the management of multiple myeloma, including advances in treatment, areas of unmet need, future directions for oncology management, and the potential impact of newer payment and practice models. These topics were discussed in the context of the payer audience.Financial and editorial support for the roundtable meeting and publication were provided by Onyx Pharmaceuticals, Inc (South San Francisco, CA), an Amgen subsidiary.

Faculty

Ira M. Klein, MD, MBA, FACP—Moderator

National Medical Director, Clinical Thought Leadership

Office of the Chief Medical Officer

Aetna, Inc

Hartford, Connecticut

Ralph V. Boccia, MD, FACP

Center for Cancer and Blood Disorders

Bethesda, Maryland

Clinical Associate Professor of Medicine

Georgetown University

Washington, DC

Eric Cannon, PharmD, FAMCP

Chief of Pharmacy

SelectHealth

Salt Lake City, Utah

William J. Cardarelli, PharmD

Director of Pharmacy Revenue and Supply

Harvard Vanguard Medical Associates

Atrius Health

Watertown, Massachusetts

Bo Gamble, BSBA

Director of Strategic Practice Initiatives

Community Oncology Alliance

Washington, DC

Linda House, RN, BSN, MSM

Executive Vice President, External Affairs

Cancer Support Community

Washington, DC

David H. Howard, PhD

Associate Professor

Department of Health Policy and Management

Winship Cancer Center

Emory University

Atlanta, Georgia

Mary Malloy, BA, CAE

Executive Director

Michigan Society of Hematology and Oncology

Royal Oak, Michigan

R. Denise McAllister, MS, ARNP, AOCNP

Florida Cancer Specialists & Research Institute

Clearwater, Florida

Brenda Milota, RN, BSN, OCN

Stem Cell Patient Coordinator

Texas Oncology at Medical City Dallas Hospital

Dallas, Texas

Gary Rice, RPh, MS, MBA, CSP

Vice President, Clinical Services

Diplomat Specialty Pharmacy

Flint, Michigan

Michele Rice, PharmD, BCOP

Director of Pharmacy

Illinois CancerCare, PC

Peoria, Illinois

Acknowledgments

Nash Gabrail, MD, MRCP, and Jim M. Koeller, MS, participated in the roundtable meeting, and Marie Bialek, PharmD, provided editorial support for the development of the manuscript.

Faculty Disclosures

These faculty report relationships with the following organizations:

Ralph V. Boccia, MD, FACP

Consultant/paid advisory board/honoraria/lecture fees: Celgene, Onyx Pharmaceuticals, Inc

Eric Cannon, PharmD, FAMCP

Board membership: The Academy of Managed Care Pharmacy

Linda House, RN, BSN, MSM

Institutional disclosure: The Cancer Support Community has received sponsorship funding and educational grants from Celgene and Onyx Pharmaceuticals, Inc.

R. Denise McAllister, MS, ARNP, AOCNP

Employment (within past 12 months): Celgene

William J. Cardarelli, PharmD; Bo Gamble, BSBA; David H. Howard, PhD; Ira M. Klein, MD, MBA, FACP; Mary Malloy, BA, CAE; Brenda Milota, RN, BSN, OCN; Gary Rice, RPh, MS, MBA, CSP; and Michele Rice, PharmD, BCOP, report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.